Effects of Arsenic Trioxide Alone and in Combination with Bortezomib in Multiple Myeloma RPMI 8266 Cells |
Elmahi, Aadil Yousif
(Cancer Center, the First Hospital of Jilin University)
Niu, Chao (Cancer Center, the First Hospital of Jilin University) Li, Wei (Cancer Center, the First Hospital of Jilin University) Li, Dan (Cancer Center, the First Hospital of Jilin University) Wang, Guan-Jun (Cancer Center, the First Hospital of Jilin University) Hao, Shan-Shan (Cancer Center, the First Hospital of Jilin University) Cui, Jiu-Wei (Cancer Center, the First Hospital of Jilin University) |
1 | Badros AZ, Goloubeva O, Rapoport AP, et al (2005). Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients. J Clin Oncol, 23, 4089-99. DOI ScienceOn |
2 | Canestraro M, Galimberti S, Savli H, et al (2010). Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. Cancer Genet Cytogenet, 199, 110-20. DOI ScienceOn |
3 | Gupta S, Yel L, Kim D, et al (2003). Arsenic trioxide induces apoptosis in peripheral blood T lymphocyte subsets by inducing oxidative stress: a role of Bcl-2. Mol Cancer Ther, 2, 711-9. DOI |
4 | Hou J, Xiong H, Gao W, and Jiang H (2005). 2-Methoxyestradiol at low dose induces differentiation of myeloma cells. Leuk Res, 29, 1059-67. DOI ScienceOn |
5 | Johnstone RW, Ruefli AA, and Lowe SW (2002). Apoptosis: a link between cancer genetics and chemotherapy. Cell, 108, 153-64. DOI ScienceOn |
6 | Morales AA, Gutman D, Lee KP, and Boise LH (2008). BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma. Blood, 111, 5152-62. DOI ScienceOn |
7 | Mousa SA, O’Connor L, Rossman TG, and Block E (2007). Pro-angiogenesis action of arsenic and its reversal by selenium-derived compounds. Carcinogenesis, 28, 962-7. |
8 | Palumbo A, and Anderson K (2011). Multiple myeloma. N Engl J Med, 364, 1046-60. DOI ScienceOn |
9 | Sanaat Z, Rezazadeh M, Gharamaleki JV, et al (2011). Arsenic trioxide in patients with refractory multiple myeloma: a prospective, phase II, single-arm study. Acta Med Iran, 49, 504-8. |
10 | Tardy C, Codogno P, Autefage H, et al (2006). Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle). Biochim Biophys Acta, 1765, 101-25. |
11 | Wang MM, Dou HJ, Zou LF, et al (2008). [Correlation of cell cycle alteration to SOCS-1 gene demethylation induced by arsenic trioxide in myeloma cell lines]. Ai Zheng, 27, 1150-4. |
12 | Yedjou C, Tchounwou P, Jenkins J, and McMurray R (2010). Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells. J Hematol Oncol, 3, 28. DOI ScienceOn |
![]() |